Nicolas Hubacz
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Nicolas Hubacz
Apr 20, 2024, 18:05 |
Insight
Nicolas Hubacz: T Cell Vs Cancer Cell
Nicolas Hubacz, Research Products Business Development Manager at Magstim, shared a post on LinkedIn: "CAR…
Jan 1, 2024, 04:23 |
Blog
Nicolas Hubacz: Top Healthcare-Related LinkedIn Creators of 2023
Nicolas Hubacz, Research Products Business Development ManagerĀ at Magstim, posted on LinkedIn: "Top Healthcare-Related LinkedIn Creators…
Oct 25, 2023, 17:44 |
Drugs
Nicolas Hubacz: Top Selling Pharmaceuticals of 2023
Nicolas Hubacz shared on LinkedIn: "Top Selling Pharmaceuticals of 2023. As the COVID-19 pandemic's grip…
Aug 1, 2023, 05:25 |
Blog
Understanding the genetic abnormalities in different cancers - Nicolas Hubacz
The visual representation below illustrates the primary cancer genes associated with certain types of cancers.…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube